MedTrace Logo

Validation of Appetite Method Visual Analogue Scales in Home-setting: VASA-home

NCT05004584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2021-12-15

No results posted yet for this study

Summary

The overall aim is to investigate whether there is a difference between methods when a standardized visual analogue scale is used to measure appetite in the home-setting compared to a monitored clinical setting. Furthermore, the intention is to investigate differences in appetite response between diets based on rye or wheat products, as well as the effects on postprandial metabolic response to such diets. Lastly, the effect of venous blood collection on subjective appetite response will be evaluated.

Conditions

  • Overweight and Obesity
  • Appetitive Behavior

Interventions

OTHER

Wheat home-based appetite assessment

Home-based appetite assessment with diet based on wheat cereal products.

OTHER

Rye home-based appetite assessment

Home-based appetite assessment with diet based on rye cereal products.

OTHER

Wheat clinic-based appetite assessment

Clinic-based appetite assessment with diet based on wheat cereal products.

OTHER

Rye clinic-based appetite assessment

Clinic-based appetite assessment with diet based on rye cereal products.

OTHER

Rye/Wheat clinic-based appetite assessment with blood sampling

Clinic-based appetite assessment with diet based on rye or wheat cereal products and continuous blood sampling.

Sponsors & Collaborators

  • Chalmers University of Technology

    lead OTHER

Principal Investigators

  • Rikard Landberg, Dr · Chalmers University of Technology

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2021-11-16
Completion
2021-11-16

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05004584 on ClinicalTrials.gov